Morphologic, immunophenotypic, and molecular evaluation of bone marrow involvement in non-Hodgkin's lymphoma

Diagnostic Molecular Pathology

Volumn 7, Issue 2, 1998, Pages 90-95

  Crotty, Paul L ^a   Smith, Brian R ^a   Tallini, Giovanni ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; IMMUNOGLOBULIN HEAVY CHAIN; LYMPHOCYTE ANTIGEN RECEPTOR; T LYMPHOCYTE RECEPTOR;

ARTICLE; BONE MARROW; FLOW CYTOMETRY; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MORPHOLOGY; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANTIGENS, CD; BONE MARROW; BONE MARROW EXAMINATION; CLONE CELLS; FLOW CYTOMETRY; GENE REARRANGEMENT, B-LYMPHOCYTE; GENE REARRANGEMENT, T-LYMPHOCYTE; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, B-CELL; LYMPHOMA, NON-HODGKIN; LYMPHOMA, T-CELL; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; TUMOR STEM CELLS;

EID: 0031708744     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-199804000-00005     Document Type: Article

References (25)

1. Berliner N, Ault KA, Martin P, Weinberg DS. Detection of clonal excess in lymphoproliferative disease by kappa/lambda analysis: correlation with immunoglobulin gene DNA rearrangement. Blood 1986;67:80-5.
2. Berliner N, Smith BR. Pathobiology of lymphoproliferative disease. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, eds. Hematology: basic principles and practice. New York: Churchill Livingston, 1995:1193-218.
3. Brunning RD, McKenna RW. Tumors of the bone marrow. In: Rosai J, ed. Atlas of Tumor Pathology, vol. 9, third series. Washington, DC: Armed Forces Institute of Pathology, 1994.
4. Coad JE, Olson DJ, Christensen DR, et al. Correlation of PCR-detected clonal gene rearrangements with bone marrow morphology in patients with B-lineage lymphomas. Am J Surg Pathol 1997;21:1047-56.
5. Coad JE, Olson DJ, Lander TA, McGlennen RC. The molecular assessment of clonality in lymphoproliferative disorders. I. Immunoglobulin gene rearrangements. Molecular Diagnostics 1996;1: 335-55.
6. Conlan MG, Bast M, Armitage JO, Weisenburger DD. Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group. J Clin Oncol 1990;8:1163-72.
7. Cossman J, Zehnbauer B, Garrett CT, et al. Gene rearrangements in the diagnosis of lymphoma/leukemia. Guidelines for use based on a multiinstitutional study [see comments]. Am J Clin Pathol 1991;95:347-54.
8. Foucar K, McKenna RW, Frizzera G, Brunning RD. Incidence and patterns of bone marrow and blood involvement by lymphoma in relationship to the Lukes-Collins classification. Blood 1979;54: 1417-22.
9. Foucar K, McKenna RW, Frizzera G, Brunning RD. Bone marrow and blood involvement by lymphoma in relationship to the Lukes-Collins classification. Cancer 1982;49:888-97.
10. Gaulard P, Kanavaros P, Farcet JP, et al. Bone marrow histologic and immunohistochemical findings in peripheral. T-cell lymphoma: a study of 38 cases. Hum Pathol 1991;22:331-8.
11. Greiner TC, Raffeld M, Lutz C, Dick F, Jaffe ES. Analysis of T cell receptor-gamma gene rearrangements by denaturing gradient gel electrophoresis of GC-clamped polymerase chain reaction products. Correlation with tumor-specific sequences. Am J Pathol 1995;146:46-55.
12. Gribben JG, Neuberg D, Freedman AS, et al. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 1993;81: 3449-57.
13. Hanson CA, Brunning RD, Gajl-Peczalska KJ, Frizzera G, McKenna RW. Bone marrow manifestations of peripheral T-cell lymphoma. A study of 30 cases. Am J Clin Pathol 1986;86:449-60.
14. Juneja SK, Wolf MM, Cooper IA. Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphoma [see comments]. J Clin Pathol 1990;43:630-2.
15. Lai HS, Tien HF, Hsieh HC, et al. Bone marrow involvement in non-Hodgkin's lymphoma. Taiwan I Hsueh Hui Tsa Chih 1989; 88:114-21.
16. Picker LJ, Weiss LM, Medeiros LJ, Wood GS, Warnke RA. Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma [review]. Am J Pathol 1987;128:181-201.
17. Roberts WM, Estrov Z, Ouspenskaia MV, Johnston DA, McClain KL, Zipf TF. Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia. N Engl J Med 1997; 336:317-23.
18. Salhany KE, Greer JP, Cousar JB, Collins RD. Marrow involvement in cutaneous T-cell lymphoma. A clinicopathologic study of 60 cases [see comments]. Am J Clin Pathol 1989;92:747-54.
19. Sharp JG, Joshi SS, Armitage JO, et al. Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture technique. Blood 1992;79:1074-80.
20. Smith BR. Integrating flow cytometry into the hematology laboratory: a curmudgeon's view. Ann N Y Acad Sci 1993;677: 326-33.
21. Smith BR, Weinberg DS, Robert NJ, et al. Circulating monoclonal B lymphocytes in non-Hodgkin's lymphoma. N Engl J Med 1984; 311:1476-81.
22. Specht L. Staging systems and staging investigations. In: Magrath I, ed. The non-Hodgkin's lymphomas. London: Arnold, 1997:533-76.
23. Weisenburger DD, Duggan MJ, Perry DA, Sanger WG, Armitage JO. Non-Hodgkin's lymphomas of mantle zone origin [review]. Pathology Annual 1991;1:139-58.
24. Yu L, Sun Y, Liu J. The clinical significance of detecting minimal residual disease in the bone marrow of patients with B-cell neoplasm [Chinese]. Chung Hua Nei Ko Tsa Chih 1995;34:22-5.
25. Zhang W, Zhu P, Yu S. Detection of minimal disease in bone marrow from non-Hodgkin's lymphoma and its clinical significance [Chinese]. Chung Hua I Hsueh Tsa Chih 1996;76:207-10.